Bharat Biotech completes phase-III trials for nasal Covid vaccine

Bharat Biotech International Ltd (BBIL) on Monday said it has completed the phase-III and booster dose trials for its intranasal Covid-19 vaccine BBV154, and it has proven to be safe. Photograph:......

Covaxin for kids: Bharat Biotech completes phase 2/3 trials

Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the Drugs Controller......

Bharat Biotech making single-dose intranasal Covid vaccine

Efforts are being ramped up for massive production of vaccines and make them available in the shortest possible time, a top government official said on Wednesday, stressing that India currently has......

Brazil suspends Bharat Biotech's Covaxin clinical trials

Brazil has suspended the clinical studies of Bharat Biotech's COVID-19 vaccine, Covaxin following termination of the company's agreement with its partner there, the South American Country's......

Meet the man behind India's Genome Valley

This is the amazing story of Dr Krishna M Ella, a scientist who turned into a serial entrepreneur. Krishna Ella, chairman and managing director of Bharat Biotech International Ltd, is one of the......

Hyderabad: India's Genome Valley

"If Bangalore is the Silicon Valley, Hyderabad is the Genome Valley. India's future is in biotechnology," Andhra Pradesh Chief Minister Dr Y S Rajasekhara Reddy is excited as he makes a......

Making of India's genome valley

When the Andhra Pradesh government identified biotechnology as one of the engines of economic growth for the state, it came as a surprise for many. After all, Shantha Biotech and Bharat Biotech......

Another IT hub emerges in Andhra

Madhurawada, located along the north-east of Vizag or Visakhapatnam, along National Highway-5, is an upcoming residential area, thanks to the major developments driven by the Information Technology......